Lantheus Holdings, Inc., Progenics Pharmaceuticals, Inc. - M&A Call Transcript
Good morning, and welcome to Lantheus Holdings and Progenics conference call regarding Lantheus' agreement to acquire Progenics. I'd like to remind everyone that a supplementary presentation will be used during today's call, which can be downloaded from a dedicated transaction website, www.lantheusprogenics.transactionannouncement.com.
Now I'd like to turn the call over to Mark Kinarney, Director of Investor Relations at Lantheus.
Good morning, everyone. I would like to welcome everyone to our joint Lantheus Holdings and Progenics conference call regarding Lantheus' agreement to acquire Progenics. Joining me on the call today are Mary Anne Heino, Lantheus Holdings' President and CEO; Bob Marshall, Lantheus Holdings' CFO and Treasurer; Mark Baker, CEO of Progenics; and Pat Fabbio, Executive Vice President and CFO of Progenics.
This morning, we issued a press release announcing that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |